Evidence map›Paper›PMID 38414100›Full record

Trial reportDrug testing and analysis2024

Detection of Δ

Anastasia Suraev, Danielle McCartney, Richard Kevin, Rebecca Gordon, Ronald R Grunstein, Camilla M Hoyos, Iain S McGregor

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Drug testing and analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Detection of ΔDrug testing and analysis · 2024
    Trial
  4. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  5. Interpol review of forensic toxicology, 2023-2025.Forensic science international. Synergy · 2026
    Review
  6. Article
  7. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder.International journal of molecular sciences · 2025
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anastasia SuraevLambert Initiative for Cannabinoid Therapeutics, University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-5993-2246
Danielle McCartneyLambert Initiative for Cannabinoid Therapeutics, University of Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-7783-5220
Richard KevinLambert Initiative for Cannabinoid Therapeutics, University of Sydney, Sydney, New South Wales, Australia.
Rebecca GordonLambert Initiative for Cannabinoid Therapeutics, University of Sydney, Sydney, New South Wales, Australia.
Ronald R GrunsteinCentre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia.
Camilla M HoyosCentre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Sydney, New South Wales, Australia.
Iain S McGregorLambert Initiative for Cannabinoid Therapeutics, University of Sydney, Sydney, New South Wales, Australia.
The University of Sydney · AUWoolcock Institute of Medical Research · AU

Funding

Lambert Initiative for Cannabinoid Therapeutics
6 · The paper itself

Abstract

Point-of-collection testing (POCT) devices are widely used in roadside and workplace drug testing to identify recent cannabis use by measuring the presence of Δ

Indexed as

CannabidiolCross-Over StudiesDronabinolSalivaSubstance Abuse DetectionAdministration, OralAdultChromatography, LiquidDouble-Blind MethodFemaleHumansMaleMedical MarijuanaMiddle AgedSleep Initiation and Maintenance DisordersTandem Mass SpectrometryCannabidiolDronabinolMedical Marijuanacannabisdrug testingoral fluidpoint‐of‐collection testingTHC

Identifiers

PMID38414100
PMCPMC11635059
OpenAlexW4392235538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.